Serum Phenylalanine Concentration As a Marker of Liver Function in Obese Patients Before and After Bariatric Surgery

Overview

Journal Obes Surg

Date 2008 Apr 24

PMID 18431611

Citations 24

Authors

Julian Swierczynski

Tomasz Sledzinski

Ewa Slominska

Ryszard Smolenski

Zbigniew Sledzinski

Affiliations

Soon will be listed here.

Abstract

Background: Human obesity is associated with increased serum phenylalanine concentration, which is probably caused by liver dysfunction related to liver steatosis. This study examines whether improvements of liver function after bariatric surgery is associated with a decrease of serum phenylalanine concentration caused by an increase of phenylalanine metabolism.

Method: Serum phenylalanine and alanine aminotransferase (an independent predictor of liver steatosis) concentrations as well as several parameters related to obesity were measured in 16 obese patients (seven men and nine women) before and 6 months after vertical banded gastroplasty. Ten (six men and four women) lean, healthy subjects served as controls.

Results: Obese patients before surgery had approximately twofold higher serum phenylalanine concentration than control subjects. The serum phenylalanine concentration decreased 6 months after bariatric surgery. Serum alanine aminotransferase (ALT) concentration was higher in obese patients before surgery, and decreased 6 months after bariatric surgery. Changes in serum phenylalanine concentration correlated positively with changes of ALT concentration (r = 0.75; p < 0.001). The body weight, BMI, HOMA-IR, serum triacylglycerol, LDL-cholesterol/HLD-cholesterol ratio, leptin, insulin, and glucose concentrations were higher in obese patients, and decreased 6 months after bariatric surgery. Serum HDL-cholesterol concentration was lower in obese patients before surgery than in control subjects and increased 6 months after surgery.

Conclusion: Results obtained indicate that bariatric surgery-induced weight loss had beneficial effects on several laboratory parameters including serum phenylalanine, ALT, lipid concentrations and insulin resistance. A strong positive correlation between serum phenylalanine and serum ALT concentrations suggests that deterioration of liver function in obese patients is contributing to a decrease in phenylalanine metabolism and consequently to the increase of serum phenylalanine concentration. One can suppose that serum phenylalanine concentration could be noninvasive marker of liver dysfunction associated with liver steatosis in obese patients.

Citing Articles

Bariatric Surgery in Obesity: Metabolic Quality Analysis and Comparison of Surgical Options.

Engin A Adv Exp Med Biol. 2024; 1460:697-726.

PMID: 39287870 DOI: 10.1007/978-3-031-63657-8_24.

Circulatory Metabolite Ratios as Indicators of Lifestyle Risk Factors Based on a Greek NAFLD Case-Control Study.

Fotakis C, Amanatidou A, Kafyra M, Andreou V, Kalafati I, Zervou M Nutrients. 2024; 16(8).

PMID: 38674925 PMC: 11055137. DOI: 10.3390/nu16081235.

Interindividual- and blood-correlated sweat phenylalanine multimodal analytical biochips for tracking exercise metabolism.

Zhong B, Qin X, Xu H, Liu L, Li L, Li Z Nat Commun. 2024; 15(1):624.

PMID: 38245507 PMC: 10799919. DOI: 10.1038/s41467-024-44751-z.

Abnormal Phenylalanine Metabolism of in Chronic Selenosis in Selenium-Enriched Habitats.

Ren H, Zhou P, Shen X Metabolites. 2023; 13(9).

PMID: 37755262 PMC: 10537570. DOI: 10.3390/metabo13090982.

Plasma Amino Acids in NAFLD Patients with Obesity Are Associated with Steatosis and Fibrosis: Results from the MAST4HEALTH Study.

Amanatidou A, Mikropoulou E, Amerikanou C, Milanovic M, Stojanoski S, Bjelan M Metabolites. 2023; 13(8).

PMID: 37623902 PMC: 10456787. DOI: 10.3390/metabo13080959.

References

Zabrocka L, Raczynska S, Goyke E, Sledzinski Z, Swierczynski J . BMI is the main determinant of the circulating leptin in women after vertical banded gastroplasty. Obes Res. 2004; 12(3):505-12. DOI: 10.1038/oby.2004.57. View

Ishii Y, Suzuki S, Kohno T, Aoki M, Goto I, Kohno T . Patients with severe liver cirrhosis followed up by L-[1-(13)C] phenylalanine breath test. J Gastroenterol. 2003; 38(11):1086-90. DOI: 10.1007/s00535-003-1201-0. View

Clark J, Alkhuraishi A, Solga S, Alli P, Diehl A, Magnuson T . Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease. Obes Res. 2005; 13(7):1180-6. DOI: 10.1038/oby.2005.140. View

Burke P, Stack J, Wagner D, Lewis D, Jenkins R, Forse R . L-[1-(13)C] Phenylalanine oxidation as a measure of hepatocyte functional capacity in end-stage liver disease. Am J Surg. 1997; 173(4):270-3; discussion 273-4. DOI: 10.1016/S0002-9610(96)00392-3. View

Marchesini G, Brizi M, Morselli-Labate A, Bianchi G, Bugianesi E, McCullough A . Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999; 107(5):450-5. DOI: 10.1016/s0002-9343(99)00271-5. View

Chang Y, Ryu S, Sung E, Jang Y . Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem. 2007; 53(4):686-92. DOI: 10.1373/clinchem.2006.081257. View

Talwalkar J . Motion - all patients with NASH need to have a liver biopsy: arguments for the motion. Can J Gastroenterol. 2002; 16(10):718-21. DOI: 10.1155/2002/759701. View

Moretto M, Kupski C, Mottin C, Repetto G, Toneto M, Rizzolli J . Hepatic steatosis in patients undergoing bariatric surgery and its relationship to body mass index and co-morbidities. Obes Surg. 2003; 13(4):622-4. DOI: 10.1381/096089203322190853. View

Zello G, Pencharz P, Ball R . Phenylalanine flux, oxidation, and conversion to tyrosine in humans studied with L-[1-13C]phenylalanine. Am J Physiol. 1990; 259(6 Pt 1):E835-43. DOI: 10.1152/ajpendo.1990.259.6.E835. View

10.

FELIG P, Marliss E, Cahill Jr G . Plasma amino acid levels and insulin secretion in obesity. N Engl J Med. 1969; 281(15):811-6. DOI: 10.1056/NEJM196910092811503. View

11.

Swierczynski J, Korczynska J, Goyke E, Adrych K, Raczynska S, Sledzinski Z . Serum hepatocyte growth factor concentration in obese women decreases after vertical banded gastroplasty. Obes Surg. 2005; 15(6):803-8. DOI: 10.1381/0960892054222678. View

12.

Ishii Y, Suzuki S, Kohno T, Aoki M, Kohno T, Ito A . L-[1-13C] phenylalanine breath test reflects histological changes in the liver. J Surg Res. 2003; 114(2):120-5. DOI: 10.1016/s0022-4804(03)00278-6. View

13.

Caballero B, Finer N, Wurtman R . Plasma amino acids and insulin levels in obesity: response to carbohydrate intake and tryptophan supplements. Metabolism. 1988; 37(7):672-6. DOI: 10.1016/0026-0495(88)90089-3. View

14.

Palova S, Charvat J, Masopust J, Klapkova E, Kvapil M . Changes in the plasma amino acid profile in anorexia nervosa. J Int Med Res. 2007; 35(3):389-94. DOI: 10.1177/147323000703500314. View

15.

Laurin J . Motion - all patients with NASH need to have a liver biopsy: arguments against the motion. Can J Gastroenterol. 2002; 16(10):722-6. DOI: 10.1155/2002/614302. View

16.

Kaplan L . Leptin, obesity, and liver disease. Gastroenterology. 1998; 115(4):997-1001. DOI: 10.1016/s0016-5085(98)70272-0. View

17.

Myers M, Cowley M, Munzberg H . Mechanisms of leptin action and leptin resistance. Annu Rev Physiol. 2007; 70:537-56. DOI: 10.1146/annurev.physiol.70.113006.100707. View

18.

Poynard T, Ratziu V, Charlotte F, Messous D, Munteanu M, Imbert-Bismut F . Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 2006; 6:34. PMC: 1657015. DOI: 10.1186/1471-230X-6-34. View

19.

FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

20.

Pearl R, CLOWES Jr G, Bosari S, McDermott W, Menzoian J, Love W . Amino acid clearance in cirrhosis. A predictor of postoperative morbidity and mortality. Arch Surg. 1987; 122(4):468-73. DOI: 10.1001/archsurg.1987.01400160094015. View